Xin Yue
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Xin Yue has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Adam Ioannou
National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom
1 shared publication Hongmei He
Statistical Medicine and Preventive Medicine Basic Medical College of Henan University Kaifeng China
1 shared publication- Licheng Wang
Department of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China
1 shared publication - Linmiao Zeng
Department of Respiratory and Critical Care Medicine Mindong Hospital Affiliated to Fujian Medical University Fu'an City China
1 shared publication Linning Wang
Department of Cardiovascular Surgery Zhengzhou Seventh People’s Hospital Zhengzhou China
1 shared publication- Long Zuo
Department of Radiology, Beijing Chaoyang Hospital Capital Medical University Beijing China
1 shared publication
Latest Publications
- Open Access
- 1 December 2021
- Published by Wiley in Cochrane Database of Systematic Reviews
- Vol. 2021 (12)
Coronary artery bypass surgery versus medical therapy alone for ischaemic heart disease
Objectives This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the effects of coronary artery bypass surgery versus medical therapy alone in people with ischaemic heart disease.
- 1 December 2021
- Published by Wiley in Cochrane Database of Systematic Reviews
- Vol. 2021 (12)
Open AccessCoronary artery bypass surgery versus medical therapy alone for ischaemic heart disease
Objectives This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the effects of coronary artery bypass surgery versus medical therapy alone in people with ischaemic heart disease.
- Open Access
- 10 February 2021
- Published by Wiley in Cardiology Research and Practice
- Vol. 2021, 1-7
Atrial Cardiomyopathy and Atrial Fibrillation in Cancer
The number of patients with oncologic and cardiologic comorbidities is increasing. A growing number of evidence shows an inextricable link between cancer, atrial fibrillation, and atrial cardiomyopathy. Cancer itself and resultant inflammation, anticancer treatment, and other comorbidities lead to atrial remodeling and fibrosis, which increases the tendency to develop atrial cardiomyopathy and atrial fibrillation. The scarcity of current literature and ambiguous results make its relationship difficult to fully understand. In this review, we will summarize existing evidence of the relationships and interactions among cancer, atrial cardiomyopathy, and atrial fibrillation and discuss the underlying mechanisms, and provide better information for the management of these patients.
- 10 February 2021
- Published by Wiley in Cardiology Research and Practice
- Vol. 2021, 1-7
Open AccessAtrial Cardiomyopathy and Atrial Fibrillation in Cancer
The number of patients with oncologic and cardiologic comorbidities is increasing. A growing number of evidence shows an inextricable link between cancer, atrial fibrillation, and atrial cardiomyopathy. Cancer itself and resultant inflammation, anticancer treatment, and other comorbidities lead to atrial remodeling and fibrosis, which increases the tendency to develop atrial cardiomyopathy and atrial fibrillation. The scarcity of current literature and ambiguous results make its relationship difficult to fully understand. In this review, we will summarize existing evidence of the relationships and interactions among cancer, atrial cardiomyopathy, and atrial fibrillation and discuss the underlying mechanisms, and provide better information for the management of these patients.